These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 34146510)
1. Safety and efficacy of occipital nerve stimulation for attack prevention in medically intractable chronic cluster headache (ICON): a randomised, double-blind, multicentre, phase 3, electrical dose-controlled trial. Wilbrink LA; de Coo IF; Doesborg PGG; Mulleners WM; Teernstra OPM; Bartels EC; Burger K; Wille F; van Dongen RTM; Kurt E; Spincemaille GH; Haan J; van Zwet EW; Huygen FJPM; Ferrari MD; Lancet Neurol; 2021 Jul; 20(7):515-525. PubMed ID: 34146510 [TBL] [Abstract][Full Text] [Related]
2. A prospective open label 2-8 year extension of the randomised controlled ICON trial on the long-term efficacy and safety of occipital nerve stimulation in medically intractable chronic cluster headache. Brandt RB; Wilbrink LA; de Coo IF; Haan J; Mulleners WM; Huygen FJPM; van Zwet EW; Ferrari MD; Fronczek R; EBioMedicine; 2023 Dec; 98():104895. PubMed ID: 38007947 [TBL] [Abstract][Full Text] [Related]
3. The HortONS study. Treatment of chronic cluster headache with transcutaneous electrical nerve stimulation and occipital nerve stimulation: study protocol for a prospective, investigator-initiated, double-blinded, randomized, placebo-controlled trial. Fogh-Andersen IS; Sørensen JCH; Petersen AS; Jensen RH; Meier K BMC Neurol; 2023 Oct; 23(1):379. PubMed ID: 37865755 [TBL] [Abstract][Full Text] [Related]
7. Occipital nerve stimulation for drug-resistant chronic cluster headache: a prospective pilot study. Magis D; Allena M; Bolla M; De Pasqua V; Remacle JM; Schoenen J Lancet Neurol; 2007 Apr; 6(4):314-21. PubMed ID: 17362835 [TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache: a multicentre, double-blind, randomised controlled trial. Obermann M; Nägel S; Ose C; Sonuc N; Scherag A; Storch P; Gaul C; Böger A; Kraya T; Jansen JP; Straube A; Freilinger T; Kaube H; Jürgens TP; Diener HC; Katsarava Z; Kleinschnitz C; Holle D Lancet Neurol; 2021 Jan; 20(1):29-37. PubMed ID: 33245858 [TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial. Mulleners WM; Kim BK; Láinez MJA; Lanteri-Minet M; Pozo-Rosich P; Wang S; Tockhorn-Heidenreich A; Aurora SK; Nichols RM; Yunes-Medina L; Detke HC Lancet Neurol; 2020 Oct; 19(10):814-825. PubMed ID: 32949542 [TBL] [Abstract][Full Text] [Related]
10. Occipital nerve stimulation improves the quality of life in medically-intractable chronic cluster headache: Results of an observational prospective study. Fontaine D; Blond S; Lucas C; Regis J; Donnet A; Derrey S; Guegan-Massardier E; Jarraya B; Dang-Vu B; Bourdain F; Valade D; Roos C; Creach C; Chabardes S; Giraud P; Voirin J; Bloch J; Rocca A; Colnat-Coulbois S; Caire F; Roger C; Romettino S; Lanteri-Minet M Cephalalgia; 2017 Oct; 37(12):1173-1179. PubMed ID: 27697849 [TBL] [Abstract][Full Text] [Related]
11. Suboccipital steroid injections for transitional treatment of patients with more than two cluster headache attacks per day: a randomised, double-blind, placebo-controlled trial. Leroux E; Valade D; Taifas I; Vicaut E; Chagnon M; Roos C; Ducros A Lancet Neurol; 2011 Oct; 10(10):891-7. PubMed ID: 21903477 [TBL] [Abstract][Full Text] [Related]